ICECURE MEDICAL LTD
ICCMNASDAQ🏆 #5159 by market capUS Equity
$1.62▼ $0.06 (−3.57%)
LiveTrack ICCM
Get earnings, price moves & breaking news on Telegram
24h▼ 3.6%
7d▼ 16.9%
14d▼ 21.4%
30d▼ 28.6%
ytd▼ 91.2%
1y▼ 94.8%
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
+41.6%
High Growth
📊Gross Margin
36.1%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
1.4x
Cheap
Otter Score
52
Weak
Trading Snapshot
- Day Range
- $1.61 – $1.64
- 52-Week Range
- $1.65 – $42.00
- Volume
- $3.09B
- Avg Volume
- $3.33B
- Shares Outstanding
- 3.4M
- Next Earnings
- Nov 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $907,000
- P/E Ratio
- —
- P/S Ratio
- 1.4x
- EPS (TTM)
- $-6.73
- Dividend Yield
- —
- Dilution (1yr)
- +31.0%
Why Investors Own ICCM
- ✓High-growth profile — revenue up +49.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 45% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ICECURE MEDICAL LTD
ICCMFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3M▲ +2.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
36.3%▼ −17.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$15M▼ −3.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$15M▲ +15.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.4M▲ +31.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$9M▲ +$2M YoY
StockOtter · stockotter.spaceAbout ICECURE MEDICAL LTD
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
52/100
Analyst Price Target
ⓘAverage Target
$1.71
▲ +5.3% Upside
High Target$1.90
Low Target$1.35
Based on 18 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
ICECURE MEDICAL LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift ICCM price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
ICECURE MEDICAL LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.